Xiaofeng Jiang

Xiaofeng Jiang is a Senior Scientist at EMD Serono, Inc. since May 2022, specializing in CRISPR genome editing technologies, target validation, and high-throughput screening in immunology and immuno-oncology. Previously, Jiang held a Senior Scientist position at Cellarity, leading assay development for compound screening in metabolic and rare genetic disease projects. Between February 2010 and May 2021, Jiang worked at Harvard University T H Chan School of Public Health, focusing on functional genomics and cancer-related pathways, conducting high-throughput screenings and contributing to various significant findings in therapeutic potentials and gene validations. Earlier, Jiang was a Research Fellow at Harvard Medical School and Dana-Farber Cancer Institute, investigating cancer biology and pharmacology and elucidating key cellular signaling pathways and DNA damage responses. Education was completed at Peking Union Medical College.